Helen Elizabeth Hanby
Director/Miembro de la Junta en NIGHTSTAR THERAPEUTICS PLC .
Cargos activos de Helen Elizabeth Hanby
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NIGHTSTAR THERAPEUTICS PLC | Director/Miembro de la Junta | 07/06/2019 | - |
| Secretario Corporativo | 08/08/2019 | - | |
Tungsten Bidco Ltd.
 Tungsten Bidco Ltd. Financial ConglomeratesFinance Founded in 2019, Tungsten Bidco Ltd. is a British company that functions as an investment holding company. Part of Biogen, Inc., the company is based in Maidenhead, UK. | Director/Miembro de la Junta | 04/06/2019 | - |
| Secretario Corporativo | 08/08/2019 | - | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Director/Miembro de la Junta | 07/06/2019 | - |
| Secretario Corporativo | 08/08/2019 | - |
Historial de carrera de Helen Elizabeth Hanby
Estadísticas
Internacional
| Reino Unido | 4 |
Operativa
| Director/Board Member | 3 |
| Corporate Secretary | 3 |
Sectorial
| Health Technology | 2 |
| Finance | 2 |
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
Tungsten Bidco Ltd.
Tungsten Bidco Ltd. Financial ConglomeratesFinance Founded in 2019, Tungsten Bidco Ltd. is a British company that functions as an investment holding company. Part of Biogen, Inc., the company is based in Maidenhead, UK. | Finance |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Health Services |
